Following months of concerns about whether side effects of ranitidine in Zantac increase the risk of cancer, the U.S. Food and Drug Administration (FDA) announced today that all ranitidine-based drugs should be removed from the market, including name-brand Zantac, over-the-counter and all generic equivalents. (more…) Read More
Recent testing by an independent pharmacy has confirmed that users of Zantac may have been exposed to massive amounts of the human carcinogen N-nitrosodimethylamine (NDMA). This has resulted in nationwide calls for a Zantac recall and lawsuits against the drug makers for failing to warn about… Read More
Following an alarming discovery announced by the FDA today, the lawyers at Saiontz & Kirk, P.A., are evaluating the potential for Zantac lawsuits, since the known human carcinogen N-nitrosodimethylamine (NDMA) has been found in the widely used heartburn drug. Our law firm currently represents individuals nationwide… Read More
